Innovations in health information technologies for chronic pulmonary diseases
نویسندگان
چکیده
Asthma and chronic obstructive pulmonary disease (COPD) are common chronic obstructive lung disorders in the US that affect over 49 million people. There is no cure for asthma or COPD, but clinical guidelines exist for controlling symptoms that are successful in most patients that adhere to their treatment plan. Health information technologies (HITs) are revolutionizing healthcare by becoming mainstream tools to assist patients in self-monitoring and decision-making, and subsequently, driving a shift toward a care model increasingly centered on personal adoption and use of digital and web-based tools. While the number of chronic pulmonary disease HITs is rapidly increasing, most have not been validated as clinically effective tools for the management of disease. Online communities for asthma and COPD patients are becoming sources of empowerment and support, as well as facilitators of patient-centered research efforts. In addition to empowering patients and facilitating disease self-management, HITs offer promise to aid researchers in identifying chronic pulmonary disease endotypes and personalized treatments based on patient-specific profiles that integrate symptom occurrence and medication usage with environmental and genomic data.
منابع مشابه
Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling
Background To assess whether early health economic modeling helps to distinguish those healthcare innovations that are potentially cost-effective from those that are not potentially cost-effective. We will also study what information is retrieved from the health economic models to inform further development, research and implementation decisions. Methods We performed s...
متن کاملCorrection to: Relationship between Air Pollution and Mortality Rate due to Chronic Obstructive Pulmonary Diseases in Mashhad, Iran
Correction to: Relationship between Air Pollution and Mortality Rate due to Chronic Obstructive Pulmonary Diseases in Mashhad, Iran Narges Ghorbani1, Jamshid Yazdani-Charati2, Siavash Etemadinejad3, Nasrin Ghorbani4 1 PhD Student in Biostatistics, Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran 2 Associate Professor, Department of Biostatistics,...
متن کاملEstimation of the Cost of Smoking-Attributable Diseases (Five Selected Diseases): A Case in Kerman City, Iran, 2014
Background: Cigarette seems to be the least valuable of addictive drugs. It is easily accessible to the public, and its harmful personal and social effects have attracted less attention. Therefore, the present research was carried out with the aim of presenting cost estimations of smoking-related diseases in smokers who aged 35 or higher in Kerman City, Iran, in 2014.Methods: Using the prevalen...
متن کاملThe Six-minute Walk Test (6MWT) for the Evaluation of Pulmonary Diseases
The six-minute walk test (6MWT) is a well-tolerated test which reflects daily activities and can be easily used in clinical practice. The 6MWT provides information about functional capacity, response to therapy and prognosis across a range of chronic cardiopulmonary conditions. Moreover, the 6MWT is sensitive to the common therapies used for chronic obstructive pulmonary disease, such as pulmon...
متن کاملEarly Health Economic Modelling – Optimizing Development for Medical Device Developers?; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”
This commentary considers the positive and negative consequences of early economic modelling and explores potential future directions. Early economic modelling offers device manufacturers an opportunity to assess the potential value of an innovation at an early stage of development. Early modelling can direct resources into potentially viable technologies and reduce inv...
متن کامل